AznTraderMajesty
Posted - 3 hours ago
$HUM I sold. Looks like an other leg down forming to test $200 range.
StrayTrader
Posted - 4 hours ago
@LittleJohn213 yeah and I’m out until after earnings … not interested in the volatile crapshoot $HUM
hkm_trader
Posted - 11 hours ago
$HUM where is the scam merger
dmas
Posted - 14 hours ago
Today Morgan Stanley analyst Erin Wright maintained a Hold rating on $HUM, with a $374 target. Couldn't she wait 2 days to see how earnings come out ? She does have a high success rate at rank 210 out of 9000+ analysts.
hkm_trader
Posted - 15 hours ago
$HUM no worries efficient markets gonna take care of this
HoneyBadgerOnTheRun
Posted - 15 hours ago
$HUM lot's of bears showing up before earnings... definitely will be an interesting one for sure... debating if I will hold or not 🤔
chursinow62
Posted - 15 hours ago
$HUM Broken company not worth saving. Other options🔪🔪🔪🔪
chursinow62
Posted - 15 hours ago
$HUM Get ready for the big dump
Cutlass
Posted - 17 hours ago
$HUM Out for now, (227 > 265 for 17%) don't want to hold for earnings...may get back in on an ER algo dip Wednesday - GLTA 🤠
Wallst45
Posted - 19 hours ago
$HUM strong earnings upcoming
DocHoliday7
Posted - 21 hours ago
$HUM here’s hoping management reports positive outlook for once to help buyout price .. 🥂
ChessGM
Posted - 1 day ago
$HUM Upcoming Earnings Alert for 10/30/2024 Neutral (5.5) In recent developments surrounding Humana Inc. (NYSE: HUM), the stock has been navigating considerable turbulence, primarily driven by challenges in its Medicare Advantage segment. The company faces a significant decline in the quality ratings of its Medicare plans, with only 25% of its members now enrolled in plans rated four stars or above, compared to 94% previously. This drastic drop is poised to adversely affect Humana's revenue and profitability, particularly in 2026, as it jeopardizes bonus payments from the Medicare program. Financial metrics indicate a stark shift in investor sentiment, leading to a 32% decline in stock value over the past year, with current trading around $240, down from over $560. Analysts are adjusting their forecasts, with Truist recently lowering the price target for Humana from $400 to $260, reflecting the challenging outlook within the Medicare Advantage arena. The company’s price-to-earnings (P/E) ratio has also been impacted, currently standing at approximately 12.5, significantly below the industry average of around 18, suggesting that HUM may be undervalued compared to its peers. Despite these headwinds, Humana has maintained a strong position in customer experience, ranking first among health insurers for four consecutive years, and remains committed to its philanthropic initiatives. Looking ahead, Humana's third-quarter earnings report is scheduled for October 30, 2024. Analysts are keenly observing this event, as it will provide further insights into the company's response to the Medicare rating challenges and overall strategic direction. Consensus estimates anticipate earnings per share (EPS) to be lower compared to previous guidance, influenced by the recently disclosed star rating downgrades. Historically, Humana has demonstrated resilience in its earnings, but the current environment suggests that results may fall short of market expectations, potentially exacerbating the stock's volatility. As the company prepares for this report, market participants are particularly focused on management's commentary regarding future plans, including any strategic measures to address the declining ratings and associated revenue impact. The upcoming earnings call will thus be crucial in shaping investor sentiment moving forward. - Funds were net buyers of $HUM during the previous reporting quarter. - Top 5 funds with large holdings in $HUM: * Holocene Advisors LP $196MM (Market Value). CGMFundScore: 82% * Steadfast Capital Management LP $195MM (Market Value). CGMFundScore: 79% * Starboard Value LP $189MM (Market Value). CGMFundScore: 80% * Point72 Asset Management LP $183MM (Market Value). CGMFundScore: 81% * D. E. Shaw & Co $177MM (Market Value). CGMFundScore: 82% - Last 10 days performance: -2% - Last 30 days performance: -18%. Weak price action. - Last 90 days performance: -33% Follow ChessGM! Do not miss other earnings alerts from ChessGM. Not a financial advice.
BatmanGotham1
Posted - 1 day ago
$HUM look at the gap up on $MOH after earnings. It’s been a little over done. I Can see something similar for earnings Wednesday before the bell.
chursinow62
Posted - 1 day ago
$HUM downgrades will star5 to happen after earnings $198
chursinow62
Posted - 1 day ago
$HUM When this goes under $200 maybe CI might strike up a deal after elevator down on ER day🔪🔪🔪🔪🔪🔪
Blossom_Tradez
Posted - 2 days ago
$HUM $LLY Also forgot to include $MCD. MCD is a riskier degen but will do it anyways.
Blossom_Tradez
Posted - 2 days ago
$LLY and $HUM good degen candidates for the week. Looking for more
QaB2i
Posted - 2 days ago
$HUM Is Humana the Lehman Brothers of Healthcare ?
FrnkTss
Posted - 3 days ago
$HUM down trend , gap filled https://youtu.be/4CD6cqF3_vQ
AznTraderMajesty
Posted - 3 days ago
$HUM either bag holder for a century or we see $340 like MOH
hkm_trader
Posted - 3 days ago
$HUM total scam operations
StrayTrader
Posted - 3 days ago
$HUM same garbage every day
dmas
Posted - 3 days ago
$HUM low volume and MM's keeping it pinned at 260 before earnings
Ma1achai
Posted - 3 days ago
$HUM Today's situation is exactly as I predicted, the executives colluded to destroy shareholder value to make a merger more palatable to the $CI board of directors. A thorough criminal investigation should be conducted!
rampoch
Posted - 3 days ago
$HUM there is no. Olume dont expect buyout announcement for long time imo
chursinow62
Posted - 3 days ago
$HUM unload and buy it back in the high $100’s
chursinow62
Posted - 3 days ago
$HUM Puts are dialing in for a big fall